4.3 Article

Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia

期刊

JOURNAL OF PSYCHOPHARMACOLOGY
卷 32, 期 11, 页码 1223-1232

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881118805492

关键词

Cognition; development; kynurenine 3-monooxygenase; prenatal; tryptophan

资金

  1. National Institute for Mental Health [P50 MH103222]
  2. NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH103222] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background: Several studies suggest a pathophysiologically relevant association between increased brain levels of the neuroinhibitory tryptophan metabolite kynurenic acid and cognitive dysfunctions in people with schizophrenia. Elevated kynurenic acid in schizophrenia may be secondary to a genetic alteration of kynurenine 3-monooxygenase, a pivotal enzyme in the kynurenine pathway of tryptophan degradation. In rats, prenatal exposure to kynurenine, the direct bioprecursor of kynurenic acid, induces cognitive impairments reminiscent of schizophrenia in adulthood, suggesting a developmental dimension to the link between kynurenic acid and schizophrenia. Aim: The purpose of this study was to explore the possible impact of the maternal genotype on kynurenine pathway metabolism. Methods: We exposed pregnant wild-type (Kmo(+/+)) and heterozygous (Kmo(+/-)) mice to kynurenine (10 mg/day) during the last week of gestation and determined the levels of kynurenic acid and two other neuroactive kynurenine pathway metabolites, 3-hydroxykynurenine and quinolinic acid, in fetal brain and placenta on embryonic day 17/18. Results: Maternal kynurenine treatment raised kynurenic acid levels significantly more in the brain of heterozygous offspring of Kmo(+/-) than in the brain of Kmo(+/+) offspring. Conversely, 3-hydroxykynurenine and quinolinic acid levels in the fetal brain tended to be lower in heterozygous animals derived from kynurenine-treated Kmo(+/-) mice than in corresponding Kmo(+/+) offspring. Genotype-related effects on the placenta were qualitatively similar but less pronounced. Kynurenine treatment also caused a preferential elevation in cerebral kynurenic acid levels in Kmo(+/-) compared to Kmo(+/+) dams. Conclusions: The disproportionate kynurenic acid increase in the brain of Kmo(+/-) animals indicates that the maternal Kmo genotype may play a key role in the pathophysiology of schizophrenia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据